| Primary |
| Osteoporosis |
43.6% |
| Drug Use For Unknown Indication |
28.7% |
| Osteopenia |
7.8% |
| Product Used For Unknown Indication |
7.0% |
| Hypertension |
3.1% |
| Osteoporosis Postmenopausal |
1.7% |
| Hypothyroidism |
0.9% |
| Pain |
0.9% |
| Osteoporosis Prophylaxis |
0.8% |
| Rheumatoid Arthritis |
0.7% |
| Asthma |
0.7% |
| Depression |
0.6% |
| Bone Density Decreased |
0.6% |
| Bone Disorder |
0.5% |
| Breast Cancer |
0.5% |
| Osteitis Deformans |
0.5% |
| Prophylaxis |
0.4% |
| Anxiety |
0.4% |
| Osteoarthritis |
0.3% |
| Arthritis |
0.3% |
|
| Death |
12.5% |
| Femur Fracture |
10.9% |
| Pain In Extremity |
10.3% |
| Vomiting |
7.8% |
| Myalgia |
6.4% |
| Pain |
6.2% |
| Osteonecrosis |
6.1% |
| Nausea |
4.9% |
| Pain In Jaw |
3.8% |
| Pyrexia |
3.5% |
| Weight Decreased |
3.3% |
| Influenza Like Illness |
3.2% |
| Low Turnover Osteopathy |
3.1% |
| Dyspepsia |
3.0% |
| Rash |
2.7% |
| Stomach Discomfort |
2.7% |
| Arthralgia |
2.6% |
| Hip Fracture |
2.4% |
| Stress Fracture |
2.3% |
| No Adverse Effect |
2.3% |
|
| Secondary |
| Osteoporosis |
49.1% |
| Osteopenia |
26.8% |
| Osteoporosis Prophylaxis |
3.9% |
| Hypertension |
2.6% |
| Drug Use For Unknown Indication |
2.5% |
| Product Used For Unknown Indication |
2.2% |
| Pain |
1.9% |
| Hypothyroidism |
1.4% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Depression |
1.0% |
| Osteitis Deformans |
1.0% |
| Asthma |
0.9% |
| Rheumatoid Arthritis |
0.9% |
| Hormone Replacement Therapy |
0.8% |
| Bone Loss |
0.8% |
| Osteoarthritis |
0.8% |
| Breast Cancer |
0.7% |
| Hypersensitivity |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Prophylaxis |
0.5% |
|
| Femur Fracture |
27.4% |
| Low Turnover Osteopathy |
14.0% |
| Stress Fracture |
6.3% |
| Weight Decreased |
6.3% |
| Weight Increased |
4.7% |
| Vitamin D Deficiency |
4.0% |
| Osteonecrosis |
3.5% |
| Tooth Disorder |
3.4% |
| Vertigo |
3.3% |
| Vomiting |
3.1% |
| Pain In Extremity |
3.0% |
| Urinary Tract Infection |
3.0% |
| Osteonecrosis Of Jaw |
2.7% |
| Fall |
2.5% |
| Osteoarthritis |
2.3% |
| Osteoporosis |
2.3% |
| Injury |
2.0% |
| Nausea |
2.0% |
| Tooth Fracture |
2.0% |
| Drug Ineffective |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.7% |
| Osteoporosis |
13.6% |
| Drug Use For Unknown Indication |
11.4% |
| Rheumatoid Arthritis |
9.5% |
| Hypertension |
6.5% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Pain |
3.6% |
| Osteopenia |
3.2% |
| Depression |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Prophylaxis |
1.9% |
| Crohn's Disease |
1.7% |
| Multiple Sclerosis |
1.7% |
| Anxiety |
1.5% |
| Asthma |
1.4% |
| Diabetes Mellitus |
1.4% |
| Atrial Fibrillation |
1.3% |
| Hypothyroidism |
1.3% |
| Osteoporosis Prophylaxis |
1.2% |
|
| Vomiting |
10.4% |
| Weight Decreased |
9.5% |
| Nausea |
6.3% |
| Urinary Tract Infection |
6.3% |
| Weight Increased |
6.3% |
| Drug Ineffective |
6.2% |
| Pain |
5.8% |
| Pain In Extremity |
5.3% |
| Injection Site Pain |
4.2% |
| Rash |
4.0% |
| Headache |
3.9% |
| Vision Blurred |
3.9% |
| Osteoporosis |
3.8% |
| Dyspnoea |
3.7% |
| Femur Fracture |
3.7% |
| Pneumonia |
3.7% |
| Death |
3.5% |
| Pruritus |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Urticaria |
3.0% |
|
| Interacting |
| Colon Cancer |
40.0% |
| Osteoporosis |
40.0% |
| Hypertension |
13.3% |
| Hypercholesterolaemia |
6.7% |
|
| Drug Interaction |
71.4% |
| Lower Limb Fracture |
14.3% |
| Urticaria |
14.3% |
|
